MGRC Subsidiary Signs Two Collaboration Agreements To Explore Genetic Screening Services
MGRC Subsidiary Signs Two Collaboration Agreements To Explore Genetic Screening Services
Malaysian Genomics Resource Centre Berhad's (MGRC) wholly owned subsidiary MGRC Healthcare Sdn Bhd (MGRCH) has entered into two separate collaboration agreements for the purpose of establishing strategic partnerships between the parties and to explore the possibility of cooperations for genetic screening services known as "Origene All-in-One Report" including a derivative product known as "Childhood-Onset Disease Profile" for the cell-gene therapies in respective diseases
馬來西亞基因組資源中心有限公司（MGRC）的全資子公司MGRC Healthcare Sdn Bhd（MGRCH）已簽訂了兩份單獨的合作協議，目的是建立雙方之間的戰略伙伴關係，並探討開展名爲 “Origene一體化報告” 的遺傳篩查服務的可能性，包括一種名爲 “兒童期發病概況” 的衍生產品，用於相應疾病的細胞基因療法
In a Bursa filing today, the first was expressed as a Strategic Collaboration Agreement (SCA) with Kumpulan Perubatan Penawar Sdn Bhd (KPPSB); and secondly, a SCA with Hospital Penawar Sdn Bhd (HPSB).
在今天的Bursa文件中，第一份是與Kumpulan Perubatan Penawar Sdn Bhd（KPPSB）簽訂的戰略合作協議（SCA）；其次是與佩納瓦爾醫院私人有限公司（HPSB）簽訂的SCA。
The key indicative obligations of the collaborations include MGRCH shall provide consultancy services and technical support for the Project which includes genetic screen-testing services and providing material and literature for the marketing and promotion of the Project by KPPSB and HPSB.
合作的主要指示性義務包括MGRCH應爲該項目提供諮詢服務和技術支持，其中包括基因篩查測試服務，以及爲KPPsB和HpSb的項目營銷和推廣提供材料和文獻。
KPPSB and HPSB shall have the distribution rights to provide the Product through their healthcare facilities and shall be providing consultancy services to consumers, and MGRCH, KPPSB and HPSB shall collaborate to explore the cell-gene therapies in childhood-onset disease.
KppsB和HpSb應擁有通過其醫療機構提供產品的分銷權，並應向消費者提供諮詢服務，MGRCH、KppsB和HpSb應合作探索兒童發作疾病的細胞基因療法。
MGRC is a public limited company incorporated in Malaysia and listed on the ACE Market of Bursa Malaysia Securities Berhad, with its principal activities in providing personalised and precision health solutions through genetics, genomics, immunotherapy and biopharmaceutical services as well as an investment holding company.
MGRC是一家在馬來西亞註冊的上市有限公司，在馬來西亞證券交易所的ACE市場上市，其主要業務是通過遺傳學、基因組學、免疫療法和生物製藥服務提供個性化和精準的健康解決方案，也是一家投資控股公司。
While, MGRCH is a wholly owned subsidiary of the Company, with its principal activities in supplying healthcare products and services.
同時，MGRCH是該公司的全資子公司，其主要業務是提供醫療保健產品和服務。
KPPSB is a healthcare group offering polyclinic and hospital services related to medical services such as Pharmacy, Psychiatric Specialist Clinic, Occupational Health Services, Dialysis Centre and other services in multiple locations within Johor. HPSB HPSB is a boutique hospital catering to the surrounding community and selected niche markets, offering an extensive array of specialised clinics with more than 20 specialists across a wide range of medical and surgeries disciplines to meet a wide range of unique healthcare requirements.
KppsB是一家醫療保健集團，在柔佛州的多個地點提供與醫療服務相關的綜合診所和醫院服務，例如藥房、精神科專科診所、職業健康服務、透析中心和其他服務。HpSb HpSb是一家精品醫院，面向周邊社區和選定的利基市場，提供種類繁多的專科診所，擁有20多名專科醫生，涵蓋各種醫學和外科領域，可滿足各種獨特的醫療保健需求。
The Parties are of the view that there are synergistic benefits to be derived for the SCAs through sharing and developing the knowledge and expertise of both parties in relation to the Product, which is subject to the terms and conditions of the SCAs.
雙方認爲，通過分享和發展雙方在產品方面的知識和專長，SCA可以獲得協同效益，這要受SCA的條款和條件的約束。